Today's Research Reports on Trending Tickers: Axovant Sciences and Gilead Sciences
NEW YORK, NY / ACCESSWIRE / December 14, 2018 / U.S. markets finished modestly higher on Thursday as investors continue to worry about trade tensions between the U.S. and China. The Dow Jones Industrial Average gained 0.29 percent to close at 24,597.38, while the S&P 500 Index fell 0.02 percent to close at 2,650.54. The Nasdaq Composite Index dropped 0.39 percent to close at 7,070.33.
“Trade tensions between the U.S. and China is the biggest factor creating volatility,” said the president of Caliber Financial Partners, Patrick Healey. “Investors are clinging to the recent positive news about trade negotiations, but we won’t see the end of this volatility until there is a concrete agreement in place,” Healey added.
The Market Edge Initiates Coverage on:
Axovant Sciences Ltd.
https://marketedgereport.com/report/AXON/
Gilead Sciences, Inc.
https://marketedgereport.com/report/GILD/
Axovant Sciences' stock moved 6.61% lower Thursday, to close the day at $1.13. The stock recorded a trading volume of 1,484,223 shares, which was above its three months average volume of 632,976 shares. In the last year, Axovant Sciences' shares have traded in a range of 1.02 - 6.59. The share price has gained 10.78% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $1.86 is below its 200-day moving average of $2.28. Shares of Axovant Sciences have fallen roughly 42.05 percent in the past month and are down 78.56 percent year-to-date.
Access The Market Edge's Axovant Sciences Ltd. Research Report:
https://marketedgereport.com/report/AXON/
On Thursday, shares of Gilead Sciences recorded a trading volume of 6,189,932 shares, which was below the three months average volume of 6,925,734 shares. The stock ended the day 0.33% lower at $67.35. The share price has fallen 24.78% from its 52 week high with a 52 week trading range of 64.27 - 89.54. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $69.45 is below its 200-day moving average of $73.06. Shares of the company are trading at a Price to Earnings ratio of 55.89. Shares of Gilead Sciences have fallen roughly 5.03 percent in the past month and are down 5.99 percent year-to-date.
Access The Market Edge's Gilead Sciences, Inc. Research Report:
https://marketedgereport.com/report/GILD/
Our Actionable Research on Axovant Sciences Ltd. (NASDAQ:AXON) and Gilead Sciences, Inc. (NASDAQ:GILD) can be downloaded free of charge at The Market Edge.
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: The Market Edge
